Display options
Cite
Lamberts SW, Krenning EP, Klijn JG, et al. Clinical applications of somatostatin analogs. Trends Endocrinol Metab. 1990;1(3):139-44doi: 10.1016/1043-2760(90)90025-x.
Lamberts, S. W., Krenning, E. P., Klijn, J. G., & Reubi, J. C. (1990). Clinical applications of somatostatin analogs. Trends in endocrinology and metabolism: TEM, 1(3), 139-44. https://doi.org/10.1016/1043-2760(90)90025-x
Lamberts, S W, et al. "Clinical applications of somatostatin analogs." Trends in endocrinology and metabolism: TEM vol. 1,3 (1990): 139-44. doi: https://doi.org/10.1016/1043-2760(90)90025-x
Lamberts SW, Krenning EP, Klijn JG, Reubi JC. Clinical applications of somatostatin analogs. Trends Endocrinol Metab. 1990 Jan-Feb;1(3):139-44. doi: 10.1016/1043-2760(90)90025-x. PMID: 18411107.
Copy Download .nbib Format: NLM
Share it on

Trends Endocrinol Metab. 1990 Jan-Feb;1(3):139-44. doi: 10.1016/1043-2760(90)90025-x.

Clinical applications of somatostatin analogs.

Trends in endocrinology and metabolism: TEM

S W Lamberts, E P Krenning, J G Klijn, J C Reubi

Affiliations

  1. Department of Medicine, Erasmus University, Rotterdam, The Netherlands.

PMID: 18411107 DOI: 10.1016/1043-2760(90)90025-x

Abstract

The somatostatin analog Sandostatin is successfully used in the treatment of metastatic endocrine pancreatic tumors, carcinoids, and acromegaly. In addition, somatostatin receptors are also present on other tumors in man, therefore making it possible to demonstrate these tumors by the administration of (123)I-coupled to a somatostatin analog.

Publication Types